We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
(-3.4%)
Cap. Flow
-$21B
Cap. Flow
% of AUM
-11.12%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$826M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$813M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$305M |
| 4 |
Microsoft
MSFT
|
+$261M |
| 5 |
Pinterest
PINS
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.27B |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$1.08B |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$1.02B |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$843M |
| 5 |
Linde
LIN
|
+$803M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.66% |
| 2 | Healthcare | 11.06% |
| 3 | Financials | 8.17% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Communication Services | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARTY
3876
iShares Future AI & Tech ETF
ARTY
$3.84B
| $368K | ﹤0.01% |
+8,200
| New | +$354K |
|
3877
Sundial Growers
SNDL
$315M
| $366K | ﹤0.01% |
38,554
+10,770
| +39% | +$98.4K |
|
|
TWCTW
3878
DELISTED
TWC Tech Holdings II Corp. Warrant
TWCTW
| $366K | ﹤0.01% |
+204,615
| New | +$309K |
|
3879
Turning Point Brands
TPB
$1.6B
| $365K | ﹤0.01% |
8,262
-2,169
| -21% | -$100K |
|
|
NGMS
3880
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $365K | ﹤0.01% |
+5,949
| New | +$311K |
|
3881
Standard BioTools
LAB
$321M
| $362K | ﹤0.01% |
58,740
-17,122
| -23% | -$91.5K |
|
3882
Puma Biotechnology
PBYI
$397M
| $362K | ﹤0.01% |
39,466
+688
| +2% | +$6.97K |
|
3883
BioXcel Therapeutics
BTAI
$26.6M
| $361K | ﹤0.01% |
778
| – | – |
|
|
DRRX
3884
DELISTED
DURECT Corp
DRRX
| $361K | ﹤0.01% |
22,150
+4,127
| +23% | +$72K |
|
3885
i3 Verticals
IIIV
$427M
| $361K | ﹤0.01% |
+11,980
| New | +$380K |
|
|
KLRS
3886
Kalaris Therapeutics
KLRS
$103M
| $361K | ﹤0.01% |
795
+313
| +65% | +$162K |
|
|
FFIC
3887
DELISTED
Flushing Financial
FFIC
| $360K | ﹤0.01% |
16,846
-8,074
| -32% | -$182K |
|
3888
Clearwater Paper
CLW
$369M
| $359K | ﹤0.01% |
12,784
-5,088
| -28% | -$159K |
|
3889
Sutro Biopharma
STRO
$425M
| $358K | ﹤0.01% |
+1,929
| New | +$378K |
|
3890
Alpha and Omega Semiconductor
AOSL
$1.01B
| $357K | ﹤0.01% |
+11,724
| New | +$360K |
|
3891
Keros Therapeutics
KROS
$203M
| $356K | ﹤0.01% |
8,367
+2,086
| +33% | +$113K |
|
3892
Five Point Holdings
FPH
$379M
| $354K | ﹤0.01% |
42,794
+819
| +2% | +$6.21K |
|
3893
Rush Street Interactive
RSI
$2.92B
| $354K | ﹤0.01% |
+27,621
| New | +$371K |
|
3894
Expro Ltd
XPRO
$1.88B
| $353K | ﹤0.01% |
18,762
+5,845
| +45% | +$121K |
|
|
WCLD
3895
WisdomTree Cloud Computing Fund
WCLD
$289M
| $352K | ﹤0.01% |
+6,301
| New | +$319K |
|
|
IGMS
3896
DELISTED
IGM Biosciences
IGMS
| $351K | ﹤0.01% |
4,223
-1,871
| -31% | -$139K |
|
|
GTS
3897
DELISTED
Triple-S Management Corporation
GTS
| $351K | ﹤0.01% |
15,788
-9,061
| -36% | -$225K |
|
3898
Barrett Business Services
BBSI
$984M
| $350K | ﹤0.01% |
19,260
-1,312
| -6% | -$24K |
|
3899
International Seaways
INSW
$4.58B
| $350K | ﹤0.01% |
18,249
-10,691
| -37% | -$208K |
|
3900
V2X
VVX
$2.47B
| $350K | ﹤0.01% |
7,273
+824
| +13% | +$42.4K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2021 Portfolio in Review
As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.
- Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
- Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
- Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
- Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
- Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
- Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
- Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.
Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.